Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1996
08/13/1996US5545671 Antimetastically acting agents
08/13/1996US5545670 Administering to human suffering from myalgic encephalomyelitis a daily dose of formulation consisting of l-methionine and its salts, inoraginc magnesium salts and chelates, folic acid, vitamin b6 and vitamine b12
08/13/1996US5545669 Anti-inflammatory compounds
08/13/1996US5545668 Oral glutamine to reduce stomatitis
08/13/1996US5545667 Administering zwitterionic surfactant antitumor agents
08/13/1996US5545665 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
08/13/1996US5545662 Used to accelerate recovery from neutropenia accompanying radio or chemotherapy, bone marrow transplantation, or infections
08/13/1996US5545661 Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds
08/13/1996US5545659 Hydroxylamines with hypoglycemic activity
08/13/1996US5545656 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
08/13/1996US5545654 Bactericides
08/13/1996US5545653 Anti-viral compounds
08/13/1996US5545652 Triazole and imidazole compounds and their use as antifungal therapeutic agents
08/13/1996US5545651 Hypotensive agents
08/13/1996US5545650 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment
08/13/1996US5545649 Administering to human or animal effective amount to parabactin or salts to inhibit proliferation of malignant cells
08/13/1996US5545648 Use of 4-aminopyridine in the reduction of chronic pain and spasticity in a spinal cord injured patient
08/13/1996US5545646 4-bicyclically substituted dihydropyridines and their use in medicaments
08/13/1996US5545645 Heterocyclic derivatives in the treatment of ischaemia and related diseases
08/13/1996US5545644 Indole derivatives
08/13/1996US5545643 Useful for treating diseases of central nervous system
08/13/1996US5545642 Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthridonecarboxylic acid
08/13/1996US5545641 Methods of inhibiting physiological conditions associated with an excess of bradykinin
08/13/1996US5545640 Viricides, hiv; aids
08/13/1996US5545639 Using 2,9-bis(halomethyl)-1,10-phenanthroline
08/13/1996US5545638 Method of treating gastrointestinal motility disorders
08/13/1996US5545637 Process for preparing pharmaceutical compositions containing crystalline anhydrous mycophenolate mofetil salts
08/13/1996US5545635 Inhibiting bone loss with equilenin
08/13/1996US5545634 Therapy, prevention of breast and endometrial cancer
08/13/1996US5545633 Triplet-sensitized photoisomerization; dehydration; protecting; deprotecting; separation
08/13/1996US5545632 Administering inositol triphosphate isomer to human or mammal to prevent or treat aids
08/13/1996US5545631 N-substituted aminoalkanephosphinic acid derivatives, compositions thereof, and their use as anti-epileptics
08/13/1996US5545628 Pharmaceutical composition containing fenofibrate
08/13/1996US5545626 Decrease intraocular pressure
08/13/1996US5545625 Hypotensive therapy
08/13/1996US5545624 Useful in treating bacterial or mycoplasmic infections
08/13/1996US5545623 Administering digitalis derivatives
08/13/1996US5545617 Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
08/13/1996US5545614 Controlling nitrogen oxide concentrations to modulate skeletal muscle contraction
08/13/1996US5545569 Immobilizing capture moiety that binds transforming growth factor-beta, adding serum from patient to form capture complex, adding labeled signal moiety that binds with complex, determining detectable label, presence of factor
08/13/1996US5545549 DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
08/13/1996US5545520 Detection of herpes virus infections
08/13/1996US5545413 Dosage form for administering oral hypoglycemic glipizide
08/13/1996US5545407 Dermatological compositions and method of treatment of skin lesions therewith using benzoyl peroxide and tocopherol esters
08/13/1996US5545401 Prevents sexually transmitted diseases; introduced to vagina, prior to intercourse in the form of gel or foam
08/13/1996US5545399 Mixture of hydrochalcone derivative and retinol or derivative thereof
08/13/1996US5545398 Hair protection; cosmetics; moisturizers; skin disorders; free radical scavengers; radiatin and oxidation resistance
08/13/1996CA2112501C Therapeutic composition for treating ent disorders
08/13/1996CA2100066C Michellamines useful as antiviral agents, composition and method of treatment
08/13/1996CA2008107C 3- or 4-substituted oxotremorine derivatives
08/13/1996CA1338519C Antiglaucoma compositions containing combinations of sympathomimetic agents and beta-1 selective beta-blockers
08/11/1996CA2169247A1 Pharmaceutical compositions and method for the treatment of patients having fragile x syndrome and retarded maturities or affected by alzheimer's type diseases or huntington's chorea or who show similar symptoms of muscular hypotonie and similar s ates
08/11/1996CA2169136A1 Use of src sh2 specific compounds to treat a bone resorption disease
08/11/1996CA2169132A1 Use of hcp sh2 specific compounds to enhance erythropoiesis
08/10/1996CA2169112A1 1-¬2-(substituted vinyl)|-3,4-dihydro-5h-2,3-benzodiazepine derivatives
08/09/1996CA2168066A1 Treatment of hypertension and congestive heart failure
08/08/1996WO1996024061A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries
08/08/1996WO1996023896A1 Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
08/08/1996WO1996023794A1 High molecular weight polymer-based prodrugs
08/08/1996WO1996023791A1 Bridged indoles as matrix metalloprotease inhibitors
08/08/1996WO1996023788A1 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/08/1996WO1996023785A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
08/08/1996WO1996023784A1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
08/08/1996WO1996023783A1 Indole derivatives as 5-ht receptor antagonist
08/08/1996WO1996023773A1 4-oxo-2-butenoic acid derivatives
08/08/1996WO1996023771A2 Platelet aggregation inhibitors
08/08/1996WO1996023769A2 Heterocyclic compounds possessing 5ht2c receptor antagonist activity
08/08/1996WO1996023760A1 2-aminoindans as selective dopamine d3 ligands
08/08/1996WO1996023523A1 Novel hemostatic composition
08/08/1996WO1996023510A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
08/08/1996WO1996023509A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
08/08/1996WO1996023507A1 Sucralfate preparation
08/08/1996WO1996023506A1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment and medicaments containing said nucleosides
08/08/1996WO1996023505A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996WO1996023504A2 Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates
08/08/1996WO1996023503A1 Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding
08/08/1996WO1996023502A1 Novel iron chelator as inhibitor of iron-mediated oxidation
08/08/1996WO1996023501A1 Methods of decreasing serum calcium levels
08/08/1996WO1996023500A1 New stable ganelic formulations containing an acid-labile benzimidazol compound, and production process
08/08/1996WO1996023499A1 Extended-release solid oral dosage forms of drugs having low solubility in water
08/08/1996WO1996023498A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
08/08/1996WO1996023497A1 Cyclopropylpyrroloindole-oligopeptide anticancer agents
08/08/1996WO1996023496A1 Use of melatonin for treating patients suffering from drug addiction
08/08/1996WO1996023495A1 Novel medical use of heme products
08/08/1996WO1996023494A1 Oral compositions of h2-antagonists
08/08/1996WO1996023493A1 New pharmaceutical composition containing trimebutine and preparation process
08/08/1996WO1996023492A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin
08/08/1996WO1996023491A1 Solid substances comprising valproic acid and sodium valproate
08/08/1996WO1996023490A1 Formulations and methods for reducing skin irritation
08/08/1996WO1996023489A2 Use of carotinoids for preparing medicaments for treating dermatoses
08/08/1996WO1996023479A2 Anti-adhesive active principles
08/08/1996WO1996023463A1 Transdermal formulation
08/08/1996WO1996023409A1 Micellar nanoparticles
08/08/1996WO1996016661A3 Use of prostaglandin e1, e2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents
08/08/1996WO1996015798A3 Use of bioassimilable boron compounds for the control of subviral pathogenic agents
08/08/1996DE4446092C1 Vitamin B¶1¶¶2¶-haltige Sanddornkonzentrate oder -extrakte Vitamin B¶1¶¶2¶-containing sea buckthorn extracts or concentrates
08/08/1996DE19503604A1 Use of carotenoid, esp. beta-carotene, to inhibit histamine release
08/08/1996DE19503423A1 Antiadhäsive Wirkstoffe Anti-adhesive agents
08/08/1996DE19503190A1 Mittel zur Beeinflussung von Störungen der Knochenbildung Means for influencing of disorders of bone formation
1 ... 6891 6892 6893 6894 6895 6896 6897 6898 6899 6900 6901 6902 6903 6904 6905 6906 6907 6908 6909 6910 6911 ... 7860